Dihydroergotamine (injection)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information about XXXXX, click here.

Synonyms / Brand Names:

Overview

Dihydroergotamine (injection)

Clinical data
ATC code	N02CA01 (WHO)
Pharmacokinetic data
Elimination half-life	9 hours
Identifiers
CAS Number	511-12-6
PubChem CID	10531
DrugBank	APRD00476
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C33H37N5O5
Molar mass	583.678 g/mol

Dihydroergotamine is an ergot alkaloid used to treat migraines.

FDA Package Insert

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

Dihydroergotamine is an ergot alkaloid used to treat migraines.

"MIGRANAL (DIHYDROERGOTAMINE MESYLATE) SPRAY [VALEANT PHARMACEUTICALS INTERNATIONAL]". </ref>

References

Template:WH Template:WS